Early Trial Offers New Hope for People With Hemophilia
WEDNESDAY, Sept. 9, 2020 — Researchers may have found a way for people with severe hemophilia to take their standard treatment less often, if the results of an early trial pan out. In what experts called a feat of bioengineering, scientists were able to create a “fusion protein” that may extend the interval between treatments… Read More »